• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

BriaCell Therapeutics Corp


Ticker Change

Company Profile for BriaCell Therapeutics Corp (ACP)

BriaCell Therapeutics Corp. operates as a breast cancer immunotherapy biotech research and developer. The Company developed a patented whole-cell vaccine, cancer immunotherapy technology called the "BriaVax" vaccine. BriaCell has offices in North America.

Contact Information

BriaCell Therapeutics Corp

Bellevue Center 235
15th Street
Vancouver, BC V7T 2X1
Phone: 1-604-921-1810
Fax: 1-604-921-1898

Key Executives for BriaCell Therapeutics Corp (ACP)

Jevin WerbesPresident/CEOMatthew G WrightChief Financial Officer
Beverley Funston "Bev"Secretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil